Blood Biomarkers in Dementia: From Research to Clinical Use
On-Demand Recording
Thanks for your interest in our STAT News webinar featuring Dr. Nicholas Ashton of the University of Gothenburg. In his presentation, Dr. Ashton explored the ways blood biomarkers are transforming research and clinical care for dementia, Alzheimer’s, and other neurodegenerative diseases. He described their evolution, from global proteomics to disease-specific markers such as p-tau, GFAP, and amyloid-beta. He also focused on the utility of plasma p-tau217 and future possibilities — including remote testing and emerging markers — to further highlight biomarkers’ potential for improving dementia diagnosis and treatment. Access the on-demand webinar to learn more.
Speaker
Nicholas Ashton, Ph.D.
Associate Professor, University of Gothenburg
After receiving his Ph.D. from King’s College, Dr. Ashton joined the University of Gothenburg, where he has made major contributions to the development and use of biofluid assays for Alzheimer’s disease and related disorders. One of the most highly-cited researchers, he has published more than 200 articles and, in 2021, received the Queen Silvia Prize for a Young Alzheimer’s Researcher.